Nippon Chemi-Con Corporation

TSE:6997.T

1078 (JPY) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 150,740161,881140,316110,788114,599140,951133,362116,311118,414123,365113,96292,959100,290127,790105,896114,578143,206135,105120,918105,714
Cost of Revenue 118,875124,954109,06389,64196,764114,256105,74893,07895,74997,95390,45282,88085,527100,94391,650102,548113,640105,26095,83483,902
Gross Profit 31,86536,92731,25321,14717,83526,69527,61423,23322,66525,41223,51010,07914,76326,84714,24612,03029,56629,84525,08421,812
Gross Profit Ratio 0.2110.2280.2230.1910.1560.1890.2070.20.1910.2060.2060.1080.1470.210.1350.1050.2060.2210.2070.206
Reseach & Development Expenses 4,4894,3834,1563,7104,1614,2884,2084,2724,3214,1603,8723,98100000000
General & Administrative Expenses 18,59723,98722,45318,17620,72721,55721,79519,89520,48420,28918,57717,06800000000
Selling & Marketing Expenses 3,8455,9155,6323,3405,0905,1264,0373,2173,3083,5243,3602,30900000000
SG&A 22,44223,98722,45318,17620,72721,55721,79519,89520,48420,28918,57717,06800000000
Other Expenses -165-37-41-253-314-1752113761551846312711226446-17
Operating Expenses 22,44223,98722,45318,17620,72721,55721,79519,89520,48420,28918,57717,06817,36018,69017,28218,90420,85920,41218,95517,094
Operating Income 9,42312,9398,7982,971-2,8915,1375,8183,3382,1795,1224,933-6,990-2,5978,157-3,036-6,8748,7079,4336,1294,718
Operating Income Ratio 0.0630.080.0630.027-0.0250.0360.0440.0290.0180.0420.043-0.075-0.0260.064-0.029-0.060.0610.070.0510.045
Total Other Income Expenses Net -28,464-8,413-19,262-716-2,254-2,875-20,796-1,388-7,7101,466-333-1,870-1,336-3,393-603146-3,821-875482-3,274
Income Before Tax -19,0414,528-10,4622,256-5,1732,263-14,9771,950-5,5306,5884,600-8,860-3,9334,764-3,639-6,7284,8868,5586,6111,444
Income Before Tax Ratio -0.1260.028-0.0750.02-0.0450.016-0.1120.017-0.0470.0530.04-0.095-0.0390.037-0.034-0.0590.0340.0630.0550.014
Income Tax Expense 2,2192,1771,6902597451,3741,1091,0991,3411,1431,2055659631,4565786,0392,3892,9762,573-1,293
Net Income -21,2902,273-12,1242,038-5,926917-16,056840-6,9055,3623,315-9,252-4,9093,297-4,294-12,7002,5125,5723,9912,659
Net Income Ratio -0.1410.014-0.0860.018-0.0520.007-0.120.007-0.0580.0430.029-0.1-0.0490.026-0.041-0.1110.0180.0410.0330.025
EPS -1,029.1112.09-597.86114.73-363.9656.31-985.7651.57-423.79329.1223.4-650.1-344.9231.7-361.06-1,032.93198.9440.7313207.3
EPS Diluted -1,029.1112.09-597.86114.59-363.9656.31-985.7651.57-423.79329.1223.4-650.1-344.9231.7-361.06-1,032.93198.9440.7313207.3
EBITDA 16,18518,32515,0878,8674,19312,52611,5489,1319,23714,60413,5183,5487,26416,5906,8806,35516,24818,61514,82512,499
EBITDA Ratio 0.1070.1130.1080.080.0370.0890.0870.0790.0780.1180.1190.0380.0720.130.0650.0550.1130.1380.1230.118